AU2001270963A1 - Transdermal drug delivery system - Google Patents

Transdermal drug delivery system

Info

Publication number
AU2001270963A1
AU2001270963A1 AU2001270963A AU7096301A AU2001270963A1 AU 2001270963 A1 AU2001270963 A1 AU 2001270963A1 AU 2001270963 A AU2001270963 A AU 2001270963A AU 7096301 A AU7096301 A AU 7096301A AU 2001270963 A1 AU2001270963 A1 AU 2001270963A1
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
transdermal drug
transdermal
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270963A
Inventor
Raphael Gorodischer
Amnon Sintov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ben Gurion University of the Negev Research and Development Authority Ltd
Original Assignee
Ben Gurion University of the Negev Research and Development Authority Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ben Gurion University of the Negev Research and Development Authority Ltd filed Critical Ben Gurion University of the Negev Research and Development Authority Ltd
Publication of AU2001270963A1 publication Critical patent/AU2001270963A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
AU2001270963A 2000-07-27 2001-07-10 Transdermal drug delivery system Abandoned AU2001270963A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL137559A IL137559A (en) 2000-07-27 2000-07-27 Transdermal drug delivery system
IL137559 2000-07-27
PCT/IL2001/000630 WO2002009763A2 (en) 2000-07-27 2001-07-10 Transdermal drug delivery system

Publications (1)

Publication Number Publication Date
AU2001270963A1 true AU2001270963A1 (en) 2002-02-13

Family

ID=11074457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270963A Abandoned AU2001270963A1 (en) 2000-07-27 2001-07-10 Transdermal drug delivery system

Country Status (6)

Country Link
US (1) US20030170296A1 (en)
EP (1) EP1307231A2 (en)
AU (1) AU2001270963A1 (en)
CA (1) CA2417275A1 (en)
IL (1) IL137559A (en)
WO (1) WO2002009763A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004000358A1 (en) * 2002-06-20 2003-12-31 Amnon Sintov Transdermal drug delivery system
ES2535045T3 (en) * 2003-04-10 2015-05-04 Vanderbilt Royalty Sub L.P. Uses and compositions for capsaicin administration
US8157788B2 (en) * 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
MXPA06012960A (en) * 2004-05-07 2007-06-12 Phytotox Ltd Transdermal administration of phycotoxins.
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
EP2216018B1 (en) 2004-10-21 2012-04-04 Durect Corporation Transdermal delivery systems
DE102005021806A1 (en) * 2005-05-04 2006-11-16 Lancaster Group Gmbh Use of radical-scavenging substances for the treatment of conditions with increased skin temperature, in particular for antipyretic treatment
US20070065494A1 (en) * 2005-08-03 2007-03-22 Watson Laboratories, Inc. Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
BRPI0812368A2 (en) * 2007-06-08 2015-02-03 Samyang Corp MATRIZ TRANSDERMAL DRUG RELEASE SYSTEMS AND THEIR PREPARATION METHOD.
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
US20100104614A1 (en) * 2008-06-27 2010-04-29 Oronsky Bryan T Providone compositions for wound healing
KR20110074611A (en) * 2008-10-21 2011-06-30 노보더믹스 인터내셔널 리미티드 Composition for treatment of epithelial tissue
IT1397246B1 (en) * 2009-05-14 2013-01-04 Fidia Farmaceutici NEW MEDICATIONS FOR TOPIC USE BASED HYALURONIC ACID SULFATED AS AN ACTIVATING OR INHABITING CITHOCINIC ACTIVITY
WO2023235688A1 (en) 2022-06-03 2023-12-07 Dow Global Technologies Llc Formulation for transdermal delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (en) * 1982-10-07 1986-05-15
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
WO1991016929A1 (en) * 1990-05-10 1991-11-14 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5985860A (en) * 1992-06-03 1999-11-16 Toppo; Frank System for transdermal delivery of pain relieving substances
DE69317781T2 (en) * 1992-07-27 1998-07-30 Procter & Gamble LAMINATED DOUBLE TEXTURED TREATMENT PADS
IL118235A0 (en) * 1996-05-13 1996-09-12 Univ Ben Gurion Composition and method for forming biodegradable implants in situ and uses of these implants
AP1209A (en) * 1996-11-14 2003-09-30 Lipomedica Ehf Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglceride derivatives thereof for treating of mucosa infections.
IT1291362B1 (en) * 1997-05-13 1999-01-07 Vectorpharma Int BIPHASIC MULTICOMPONENT PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTANCES SUITABLE TO MODIFY THE PARTITION OF THE ACTIVE SUBSTANCES
US6348212B2 (en) * 1999-05-18 2002-02-19 Lectec Corporation Treating traumatic burns or blisters of the skin
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
WO2004000358A1 (en) * 2002-06-20 2003-12-31 Amnon Sintov Transdermal drug delivery system

Also Published As

Publication number Publication date
WO2002009763A3 (en) 2002-04-18
EP1307231A2 (en) 2003-05-07
US20030170296A1 (en) 2003-09-11
CA2417275A1 (en) 2002-02-07
WO2002009763A2 (en) 2002-02-07
IL137559A (en) 2006-12-31
IL137559A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
AU2001264887A1 (en) Drug delivery device
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU2001235009A1 (en) Drug delivery apparatus
AU2001288388A1 (en) Substance delivery system
AU2001238386A1 (en) Medication delivery devices
AU4947100A (en) Drug delivery device
AU2002353444A1 (en) Integrated transdermal drug delivery system
AU2001261425A1 (en) Cases for medication delivery devices
AU2001283359A1 (en) Drug release (delivery system)
AU2001283357A1 (en) Drug delivery system with bilayer electrodes
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
AUPR573001A0 (en) Lymphatic drug delivery system
AU2002210463A1 (en) Transdermal therapeutic system
AU2001275286A1 (en) Transdermal delivery
AU2001270963A1 (en) Transdermal drug delivery system
AU2003212962A1 (en) Transdermal drug delivery systems
AU3837999A (en) Drug delivery device
AU2001243515A1 (en) Combination drug therapy
AU2003241134A1 (en) Transdermal drug delivery system
AU2002222138A1 (en) Drug delivery system
AU2002210580A1 (en) Drug delivery system
AU2001244854A1 (en) Local drug delivery
IL149115A0 (en) Transdermal drug delivery devices
AUPR146700A0 (en) Drug delivery system